Insight

Aug 14, 2024, 01:53

5 papers about lung cancer suggested by Stephen Liu

Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few must-reads papers on X:

1. Patient-reported outcomes in CodeBreak 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation

Authors: David Waterhouse et al.

Stephen Liu

2. Efficacy and safety of KRAS G12C inhibitor IBI351 monotherapy in patients with advanced non-small cell lung cancer: results from a phase 2 pivotal study

Authors: Qing Zhou et al.

Stephen Liu

Authors: Yao Ding, Shun Lei, Ling Wang, Long Tang, Yue Zhang, Yiran Liao, Xia Deng, Yan Li, Yi Gong, Yongsheng Li

Stephen Liu

4. Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial

Authors: Yi-Long Wu et al.

Stephen Liu

5. Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella a extension study

Authors: Martin Reck et al.

Stephen Liu

Follow Stephen Liu on X for more such content.

Stephen Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center.

As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies. His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer.

Dr. Liu has received multiple teaching awards and actively engages in post-graduate education initiatives. Furthermore, he co-hosts the official podcast of the International Association for the Study of Lung Cancer (IASLC), “Lung Cancer Considered”.

cancer David Waterhouse drug development Georgetown Lombardi Comprehensive Cancer Center Hui Zhou Ling Wang Long Tang Longhua Sun Lung cancer Martin Reck Maximilian Hochmair Niki Karachaliou NSCLC OncoDaily Oncology Rafal Dziadziuszko Research Sacha Rothschild Shun Lei Shunichi Sugawara Silvia Novello Stephen Liu Steven Kao Sujie Zhang Tae Min Kim Valentina Guarneri Xia Deng Xiangjiao Meng Xiuning Le Yan Li Yang Wang Yao Ding Yi Gong Yi-Long Wu Yiran Liao Yongsheng Li Yue Zhang

Mark Ruffalo and Brain Cancer: How He Went Against, How He Survived, and More

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage